Free Trial

Pyxis Oncology (PYXS) SEC Filings & 10K Form

$3.50
0.00 (0.00%)
(As of 09/6/2024 ET)

Recent Pyxis Oncology SEC Filings

DateFilerForm TypeView
08/14/2024
3:25 PM
Pyxis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/12/2024
3:17 PM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
4:31 PM
Metzger Michael A (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
4:26 PM
Metzger Michael A (Reporting)
Pyxis Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/10/2024
6:56 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
6:55 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
7:00 AM
Pyxis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:16 PM
Pyxis Oncology (Filer)
Form ARS
04/26/2024
3:15 PM
Pyxis Oncology (Filer)
Form DEF 14A
04/26/2024
3:16 PM
Pyxis Oncology (Filer)
Form DEFA14A
04/03/2024
11:15 PM
Pyxis Oncology (Filer)
Form EFFECT
03/28/2024
3:31 PM
Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:32 PM
Civik Thomas (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:32 PM
HUMPHREY RACHEL (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:33 PM
Cline Darren S (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:33 PM
Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:33 PM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
6:49 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
6:44 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
3:54 PM
Palani Santhosh (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:45 PM
Palani Santhosh (Reporting)
Pyxis Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/13/2024
3:31 PM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:02 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
8:28 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Pyxis Oncology (Subject)
Form SC 13G/A
12/29/2023
3:33 PM
Kobayashi Ken (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
3:50 PM
Kobayashi Ken (Reporting)
Pyxis Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/28/2023
6:22 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
3:44 PM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
3:46 PM
Pyxis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/27/2023
3:34 PM
Pyxis Oncology (Filer)
Form 8-K/A
09/28/2023
3:32 PM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
5:36 PM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
5:37 PM
Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2023
6:04 PM
Dupont Jakob (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2023
4:05 PM
Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2023
4:04 PM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
6:34 PM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
6:35 PM
Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
6:03 PM
Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
3:26 PM
Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/14/2023
3:43 PM
Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Biden’s Capital Gains Tax to Devastate Savings! (Ad)

Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.

>> Get Your FREE Wealth Protection Guide <<
09/13/2023
7:16 PM
Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:47 PM
Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2023
3:35 PM
Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
3:46 PM
Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PYXS) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners